跳至主要内容
临床试验/NCT05148182
NCT05148182招募中不适用

Metabolomics Characterization of Biomarkers of ASCVD and Prediction Model

Shanghai 10th People's Hospital2 个研究点 分布在 1 个国家目标入组 1,869 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,869
试验地点
2
主要终点
Coronary vascularization.

研究概览

简要总结

  1. Describe the risk factors and metabonomics characteristics of atherosclerotic cardiovascular disease in Chinese patients.
  2. Establish accurate prediction model of atherosclerotic heart disease.

详细描述

According to the Chinese cardiovascular disease report released in 2017, cardiovascular disease death is the leading cause of death of urban and rural residents, so cardiovascular disease risk assessment is particularly important. The development of cardiovascular risk assessment model was dated from Framingham Heart Study which first proposed the concept of risk factors, and then adjusted the model several times. In 2016, the China-PAR evaluated the cardiovascular disease risk of Chinese population. However, the application of metabolomics in coronary heart disease is a rapidly developing field and also a new field .

Therefore, the aim of this study was to

1.Describe the risk factors of atherosclerotic cardiovascular disease and the characteristics of metabolomics in Chinese population.

  1. Establish an accurate prediction model of atherosclerotic heart disease. Research plan:

  2. 1869 risk-stratified people were recruited.

  3. Plasma samples were collected incluing disease status and other potential influencing factors.

  4. Through the high-throughput detection of body metabolites, combined with multivariate statistical analysis, the metabolic markers with significant difference in different risk levels were screened for risk prediction.

  5. All recruited people underwent coronary angiography.

  6. The distribution of age and gender in each group should be matched and balanced as far as possible.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The age of the population is 18 or more than 18 years old.
  • According to China PAR equations, Chinese guidelines and consensus on cardiovascular risk assessment and management,it is considered as healthy, low, medium, high and extremely high risk group.
  • The subjects read and fully understood the patient's instructions and signed the informed consent

排除标准

  • Refused to sign informed consent.
  • ACS is caused by surgery, trauma, or other diseases.
  • Age less than 18 years old.
  • Pregnant women.
  • In the past 3 months, the patients were treated with trauma surgery.
  • There are aortic dissection, pulmonary embolism, pneumonia, pericarditis, myocarditis, stress cardiomyopathy.
  • Severe heart failure.
  • Liver and kidney failure.
  • Blood borne infectious diseases: including HIV / AIDS, hepatitis B, hepatitis C, etc.
  • Patients with a history of malignancies, autoimmune diseases, severe infectious diseases and trauma.
  • Any condition (such as travel, speech disorder, mental disorder) that the researcher believes can significantly limit the completion of the patient's follow-up.

结局指标

主要结局

Coronary vascularization.

时间窗: 3 years

Coronary vascularization includes percutaneous coronary intervention, or/and percutaneous coronary artery dilatation, or/and percutaneous coronary artery bypass grafting.

All cause mortality

时间窗: 3 years

which refers to the total death caused by various causes in a certain period.

Metabolomics Characterization of Biomarkers

时间窗: 3 years

Metabonomics analysis uses a non targeted detection method to detect polar compounds and lipid compounds in blood. The characteristic peaks of substances that can be detected are detected by chromatography Series platform, and then these characteristic peaks are compared with the standard library containing more than 8000 metabolites to annotate the compounds and screen out the differential metabolites between groups.

Cardiac mortality

时间窗: 3 years

Cardiac death refers to the death caused by serious cardiac dysfunction or failure which caused by heart disease or injury in a certain period.

次要结局

未报告次要终点

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ya-Wei Xu

Chief Physician

Shanghai 10th People's Hospital

研究点 (2)

Loading locations...

相似试验